Last reviewed · How we verify
NCT05599243
Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia.
Phase 2 trial testing Dutasteride in Male Androgenetic Alopecia in 45 participants. Completed in 11 August 2023.
11 August 2023
Quick facts
| Lead sponsor | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 45 |
| Start date | 29 September 2022 |
| Primary completion | 11 August 2023 |
| Estimated completion | 11 August 2023 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Dutasteride (dutasteride) — full drug profile →
- Placebo
Conditions studied
- Male Androgenetic Alopecia — all drugs for Male Androgenetic Alopecia →
Sponsor
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Who can join
18 and older, male only, with Male Androgenetic Alopecia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Alopecia is a disorder that involves the loss of hair from the body. The causes of hair loss can be multiple, but in all cases this loss causes a lot of discomfort to patients for aesthetic and psychological reasons, especially in the female population.This study is going to focus on the topical use of dutasteride in the treatment of men with androgenic alopecia using a new formulation, as an emulsion, capable of transporting this drug to the different structures of the pilosebaceous unit.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05599243
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dutasteride
Trials testing the same drug.
- NCT07417449 — Impact of Long-term Dutasteride Use on Perioperative Outcomes of HoLEP · recruiting
- NCT04947631 — Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia · Phase 3 · completed
- NCT02014584 — Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia · Phase 3 · completed
- NCT01547299 — Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Pr · Phase 2 · completed
- NCT01004809 — AVODART® Alopecia Post-marketing Surveillance (PMS) · completed
Other Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal trials
Trials by the same sponsor.
- NCT07490964 — Polycystic Ovary Syndrome in Type 1 Diabetes · not yet recruiting
- NCT07440186 — Exploratory Clinical Research for the Evaluation of Human GMP (Good Manufacturing Practice) Collagen Implants (Humabiolo · NA · not yet recruiting
- NCT07484009 — ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure · NA · recruiting
- NCT07034976 — Efficacy of Non-ablative Radiofrequency Combined With Pelvic Floor Muscle Training for Genitourinary Syndrome of Menopau · NA · recruiting
- NCT06338072 — Impact of the Menstrual Cycle in Reproductive Aged Women With Type 1 Diabetes Using a Closed Loop System (DIABETEXX/1). · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05599243 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05599243.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing